Imaging multiple sclerosis and other neurodegenerative diseases

References

• Gibb WR. Neuropathology of Parkinson’s disease and related syndromes. Neurol Clin 1992; 10:361 - 76; PMID: 1584179
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297:353 - 6; http://dx.doi.org/10.1126/science.1072994; PMID: 12130773
   PubMed Web of Science ®Google Scholar
• Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344:1688 - 700; http://dx.doi.org/10.1056/NEJM200105313442207; PMID: 11386269
   PubMed Web of Science ®Google Scholar
• Lassmann H, van Horssen J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 2011; 585:3715 - 23; http://dx.doi.org/10.1016/j.febslet.2011.08.004; PMID: 21854776
   PubMed Web of Science ®Google Scholar
• Charcot M. Histologie de la sclerose en plaques. Gazette Hopitaux 1868; 141:554 - 8
   Google Scholar
• Stadelmann C. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr Opin Neurol 2011; 24:224 - 9; http://dx.doi.org/10.1097/WCO.0b013e328346056f; PMID: 21455066
   PubMed Web of Science ®Google Scholar
• Poloni G, Minagar A, Haacke EM, Zivadinov R. Recent developments in imaging of multiple sclerosis. Neurologist 2011; 17:185 - 204; http://dx.doi.org/10.1097/NRL.0b013e31821a2643; PMID: 21712664
   PubMed Web of Science ®Google Scholar
• Oshiro S, Morioka MS, Kikuchi M. Dysregulation of iron metabolism in Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci 2011; 2011:378278; http://dx.doi.org/10.1155/2011/378278; PMID: 22013437
   PubMedGoogle Scholar
• Salvador GA. Iron in neuronal function and dysfunction. Biofactors 2010; 36:103 - 10; http://dx.doi.org/10.1002/biof.80; PMID: 20232345
   PubMed Web of Science ®Google Scholar
• LeVine SM. Iron deposits in multiple sclerosis and Alzheimer’s disease brains. Brain Res 1997; 760:298 - 303; http://dx.doi.org/10.1016/S0006-8993(97)00470-8; PMID: 9237552
   PubMed Web of Science ®Google Scholar
• Khalil M, Teunissen C, Langkammer C. Iron and neurodegeneration in multiple sclerosis. Mult Scler Int 2011; 2011:606807; http://dx.doi.org/10.1155/2011/606807; PMID: 22096640
   PubMedGoogle Scholar
• Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004; 5:863 - 73; http://dx.doi.org/10.1038/nrn1537; PMID: 15496864
   PubMed Web of Science ®Google Scholar
• Bodovitz S, Falduto MT, Frail DE, Klein WL. Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J Neurochem 1995; 64:307 - 15; http://dx.doi.org/10.1046/j.1471-4159.1995.64010307.x; PMID: 7798927
   PubMed Web of Science ®Google Scholar
• Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson’s disease. Proc Natl Acad Sci U S A 2008; 105:18578 - 83; http://dx.doi.org/10.1073/pnas.0804373105; PMID: 19011085
   PubMed Web of Science ®Google Scholar
• Gerlach M, Riederer P, Double KL. Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson’s disease. Parkinsonism Relat Disord 2008; 14:Suppl 2 S185 - 8; http://dx.doi.org/10.1016/j.parkreldis.2008.04.028; PMID: 18585086
   PubMedGoogle Scholar
• Kasarskis EJ, Tandon L, Lovell MA, Ehmann WD. Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study. J Neurol Sci 1995; 130:203 - 8; http://dx.doi.org/10.1016/0022-510X(95)00037-3; PMID: 8586987
   PubMed Web of Science ®Google Scholar
• Yoshida M, Takahashi Y, Koike A, Fukuda Y, Goto J, Tsuji S. A mutation database for amyotrophic lateral sclerosis. Hum Mutat 2010; 31:1003 - 10; http://dx.doi.org/10.1002/humu.21306; PMID: 20556799
   PubMed Web of Science ®Google Scholar
• Imam SZ, Karahalil B, Hogue BA, Souza-Pinto NC, Bohr VA. Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner. Neurobiol Aging 2006; 27:1129 - 36; http://dx.doi.org/10.1016/j.neurobiolaging.2005.06.002; PMID: 16005114
   PubMed Web of Science ®Google Scholar
• Mahad D, Ziabreva I, Lassmann H, Turnbull D. Mitochondrial defects in acute multiple sclerosis lesions. Brain 2008; 131:1722 - 35; http://dx.doi.org/10.1093/brain/awn105; PMID: 18515320
   PubMed Web of Science ®Google Scholar
• Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006; 59:478 - 89; http://dx.doi.org/10.1002/ana.20736; PMID: 16392116
   PubMed Web of Science ®Google Scholar
• Hong WK, Han EH, Kim DG, Ahn JY, Park JS, Han BG. Amyloid-beta-peptide reduces the expression level of mitochondrial cytochrome oxidase subunits. Neurochem Res 2007; 32:1483 - 8; http://dx.doi.org/10.1007/s11064-007-9336-7; PMID: 17514422
   PubMed Web of Science ®Google Scholar
• Silva DF, Esteves AR, Arduino DM, Oliveira CR, Cardoso SM. Amyloid-β-induced mitochondrial dysfunction impairs the autophagic lysosomal pathway in a tubulin dependent pathway. J Alzheimers Dis 2011; 26:565 - 81; PMID: 21694451
   PubMed Web of Science ®Google Scholar
• Mattson MP. Pathways towards and away from Alzheimer’s disease. Nature 2004; 430:631 - 9; http://dx.doi.org/10.1038/nature02621; PMID: 15295589
   PubMed Web of Science ®Google Scholar
• Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease. FASEB J 2005; 19:2040 - 1; PMID: 16210396
   PubMed Web of Science ®Google Scholar
• Danielson SR, Held JM, Oo M, Riley R, Gibson BW, Andersen JK. Quantitative mapping of reversible mitochondrial Complex I cysteine oxidation in a Parkinson disease mouse model. J Biol Chem 2011; 286:7601 - 8; http://dx.doi.org/10.1074/jbc.M110.190108; PMID: 21196577
   PubMed Web of Science ®Google Scholar
• Chinta SJ, Andersen JK. Nitrosylation and nitration of mitochondrial complex I in Parkinson’s disease. Free Radic Res 2011; 45:53 - 8; http://dx.doi.org/10.3109/10715762.2010.509398; PMID: 20815786
   PubMed Web of Science ®Google Scholar
• Chinta SJ, Mallajosyula JK, Rane A, Andersen JK. Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 2010; 486:235 - 9; http://dx.doi.org/10.1016/j.neulet.2010.09.061; PMID: 20887775
   PubMed Web of Science ®Google Scholar
• Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, Taanman JW. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet 2010; 19:4861 - 70; http://dx.doi.org/10.1093/hmg/ddq419; PMID: 20871098
   PubMed Web of Science ®Google Scholar
• Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 2005; 58:495 - 505; http://dx.doi.org/10.1002/ana.20624; PMID: 16178023
   PubMed Web of Science ®Google Scholar
• Magrané J, Sahawneh MA, Przedborski S, Estévez AG, Manfredi G. Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J Neurosci 2012; 32:229 - 42; http://dx.doi.org/10.1523/JNEUROSCI.1233-11.2012; PMID: 22219285
   PubMed Web of Science ®Google Scholar
• Igoudjil A, Magrané J, Fischer LR, Kim HJ, Hervias I, Dumont M, et al. In vivo pathogenic role of mutant SOD1 localized in the mitochondrial intermembrane space. J Neurosci 2011; 31:15826 - 37; http://dx.doi.org/10.1523/JNEUROSCI.1965-11.2011; PMID: 22049426
   PubMed Web of Science ®Google Scholar
• Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128:2705 - 12; http://dx.doi.org/10.1093/brain/awh641; PMID: 16230320
   PubMed Web of Science ®Google Scholar
• Weiner HL. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 2008; 255:Suppl 1 3 - 11; http://dx.doi.org/10.1007/s00415-008-1002-8; PMID: 18317671
   PubMed Web of Science ®Google Scholar
• Golde TE. Inflammation takes on Alzheimer disease. Nat Med 2002; 8:936 - 8; http://dx.doi.org/10.1038/nm0902-936; PMID: 12205453
   PubMed Web of Science ®Google Scholar
• McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 1988; 38:1285 - 91; http://dx.doi.org/10.1212/WNL.38.8.1285; PMID: 3399080
   PubMed Web of Science ®Google Scholar
• Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains. Acta Neuropathol 2003; 106:518 - 26; http://dx.doi.org/10.1007/s00401-003-0766-2; PMID: 14513261
   PubMed Web of Science ®Google Scholar
• De Lella Ezcurra AL, Chertoff M, Ferrari C, Graciarena M, Pitossi F. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation. Neurobiol Dis 2010; 37:630 - 40; http://dx.doi.org/10.1016/j.nbd.2009.11.018; PMID: 19969084
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease. FASEB J 2005; 19:533 - 42; http://dx.doi.org/10.1096/fj.04-2751com; PMID: 15791003
   PubMed Web of Science ®Google Scholar
• Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19:312 - 8; http://dx.doi.org/10.1016/0166-2236(96)10049-7; PMID: 8843599
   PubMed Web of Science ®Google Scholar
• Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992; 140:691 - 707; PMID: 1347673
   PubMed Web of Science ®Google Scholar
• Troost D, Van den Oord JJ, Vianney de Jong JM. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1990; 16:401 - 10; http://dx.doi.org/10.1111/j.1365-2990.1990.tb01276.x; PMID: 2263315
   PubMed Web of Science ®Google Scholar
• Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 2001; 57:1282 - 9; http://dx.doi.org/10.1212/WNL.57.7.1282; PMID: 11591849
   PubMed Web of Science ®Google Scholar
• Ciesielski-Treska J, Ulrich G, Chasserot-Golaz S, Zwiller J, Revel MO, Aunis D, et al. Mechanisms underlying neuronal death induced by chromogranin A-activated microglia. J Biol Chem 2001; 276:13113 - 20; http://dx.doi.org/10.1074/jbc.M009711200; PMID: 11124958
   PubMed Web of Science ®Google Scholar
• Mariotti R, Bentivoglio M. Activation and response to axotomy of microglia in the facial motor nuclei of G93A superoxide dismutase transgenic mice. Neurosci Lett 2000; 285:87 - 90; http://dx.doi.org/10.1016/S0304-3940(00)01034-X; PMID: 10793233
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA, De Stefano N, Enzinger C, Fisher E, Horsfield MA, et al. Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol 2011; 68:1514 - 20; http://dx.doi.org/10.1001/archneurol.2011.914; PMID: 22159052
   PubMed Web of Science ®Google Scholar
• Durand-Dubief F, Belaroussi B, Armspach JP, Dufour M, Roggerone S, Vukusic S, et al. Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques. AJNR Am J Neuroradiol 2012; http://dx.doi.org/10.3174/ajnr.A3107; PMID: 22790248
   PubMed Web of Science ®Google Scholar
• Schmierer K, Wheeler-Kingshott CA, Boulby PA, Scaravilli F, Altmann DR, Barker GJ, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2007; 35:467 - 77; http://dx.doi.org/10.1016/j.neuroimage.2006.12.010; PMID: 17258908
   PubMed Web of Science ®Google Scholar
• Mori S, van Zijl PC. Diffusion weighting by the trace of the diffusion tensor within a single scan. Magn Reson Med 1995; 33:41 - 52; http://dx.doi.org/10.1002/mrm.1910330107; PMID: 7891534
   PubMed Web of Science ®Google Scholar
• Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006; 31:1487 - 505; http://dx.doi.org/10.1016/j.neuroimage.2006.02.024; PMID: 16624579
   PubMed Web of Science ®Google Scholar
• Bonavita S, Gallo A, Sacco R, Corte MD, Bisecco A, Docimo R, et al. Distributed changes in default-mode resting-state connectivity in multiple sclerosis. Mult Scler 2011; 17:411 - 22; http://dx.doi.org/10.1177/1352458510394609; PMID: 21239414
   PubMed Web of Science ®Google Scholar
• Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000; 123:2321 - 37; http://dx.doi.org/10.1093/brain/123.11.2321; PMID: 11050032
   PubMed Web of Science ®Google Scholar
• Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, et al. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 2009; 35:306 - 28; http://dx.doi.org/10.1111/j.1365-2990.2008.01006.x; PMID: 19077109
   PubMed Web of Science ®Google Scholar
• Banati RB. Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation?. J Physiol Paris 2002; 96:289 - 99; http://dx.doi.org/10.1016/S0928-4257(02)00018-9; PMID: 12445908
   PubMed Web of Science ®Google Scholar
• Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004; 15:601 - 9; http://dx.doi.org/10.1016/j.nbd.2003.12.012; PMID: 15056468
   PubMed Web of Science ®Google Scholar
• Popescu BF, Lucchinetti CF. Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol 2012; 12:11; http://dx.doi.org/10.1186/1471-2377-12-11; PMID: 22397318
   PubMed Web of Science ®Google Scholar
• Xekardaki A, Giannakopoulos P, Haller S. White matter changes in bipolar disorder, Alzheimer disease, and mild cognitive impairment: New insights from DTI. J Aging Res 2011; 2011:286564; http://dx.doi.org/10.4061/2011/286564; PMID: 22187647
   PubMedGoogle Scholar
• Raz E, Cercignani M, Sbardella E, Totaro P, Pozzilli C, Bozzali M, et al. Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology 2010; 254:227 - 34; http://dx.doi.org/10.1148/radiol.2541090817; PMID: 20019140
   PubMed Web of Science ®Google Scholar
• Raz E, Cercignani M, Sbardella E, Totaro P, Pozzilli C, Bozzali M, et al. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology 2010; 257:448 - 54; http://dx.doi.org/10.1148/radiol.10100626; PMID: 20858849
   PubMed Web of Science ®Google Scholar
• Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O. Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum Brain Mapp 2009; 30:2852 - 61; http://dx.doi.org/10.1002/hbm.20713; PMID: 19172648
   PubMed Web of Science ®Google Scholar
• Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007; 254:1212 - 20; http://dx.doi.org/10.1007/s00415-006-0503-6; PMID: 17361339
   PubMed Web of Science ®Google Scholar
• Tsunoda I, Kuang LQ, Libbey JE, Fujinami RS. Axonal injury heralds virus-induced demyelination. Am J Pathol 2003; 162:1259 - 69; http://dx.doi.org/10.1016/S0002-9440(10)63922-3; PMID: 12651618
   PubMed Web of Science ®Google Scholar
• Inglese M, Bester M. Diffusion imaging in multiple sclerosis: research and clinical implications. NMR Biomed 2010; 23:865 - 72; http://dx.doi.org/10.1002/nbm.1515; PMID: 20882528
   PubMed Web of Science ®Google Scholar
• Preziosa P, Rocca MA, Mesaros S, Pagani E, Stosic-Opincal T, Kacar K, et al. Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. Radiology 2011; 260:541 - 50; http://dx.doi.org/10.1148/radiol.11110315; PMID: 21673227
   PubMed Web of Science ®Google Scholar
• Agosta F, Pievani M, Sala S, Geroldi C, Galluzzi S, Frisoni GB, et al. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 2011; 258:853 - 63; http://dx.doi.org/10.1148/radiol.10101284; PMID: 21177393
   PubMed Web of Science ®Google Scholar
• Sage CA, Peeters RR, Görner A, Robberecht W, Sunaert S. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 2007; 34:486 - 99; http://dx.doi.org/10.1016/j.neuroimage.2006.09.025; PMID: 17097892
   PubMed Web of Science ®Google Scholar
• Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009; 72:1378 - 84; http://dx.doi.org/10.1212/01.wnl.0000340982.01727.6e; PMID: 19129507
   PubMed Web of Science ®Google Scholar
• Kostić VS, Agosta F, Petrović I, Galantucci S, Spica V, Jecmenica-Lukic M, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010; 75:857 - 63; http://dx.doi.org/10.1212/WNL.0b013e3181f11c1d; PMID: 20686125
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA. Cortical reorganisation in patients with MS. J Neurol Neurosurg Psychiatry 2004; 75:1087 - 9; http://dx.doi.org/10.1136/jnnp.2004.036020; PMID: 15258204
   PubMed Web of Science ®Google Scholar
• Rocca MA, Pagani E, Absinta M, Valsasina P, Falini A, Scotti G, et al. Altered functional and structural connectivities in patients with MS: a 3-T study. Neurology 2007; 69:2136 - 45; http://dx.doi.org/10.1212/01.wnl.0000295504.92020.ca; PMID: 18056577
   PubMed Web of Science ®Google Scholar
• Agosta F, Pagani E, Rocca MA, Caputo D, Perini M, Salvi F, et al. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp 2007; 28:1430 - 8; http://dx.doi.org/10.1002/hbm.20364; PMID: 17370339
   PubMed Web of Science ®Google Scholar
• Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 1997; 50:345 - 53; http://dx.doi.org/10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; PMID: 9373043
   PubMed Web of Science ®Google Scholar
• Debruyne JC, Versijpt J, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, et al. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur J Neurol 2003; 10:257 - 64; http://dx.doi.org/10.1046/j.1468-1331.2003.00571.x; PMID: 12752399
   PubMed Web of Science ®Google Scholar
• Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease. Eur J Nucl Med Mol Imaging 2011; 38:343 - 51; http://dx.doi.org/10.1007/s00259-010-1612-0; PMID: 20844871
   PubMed Web of Science ®Google Scholar
• Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, et al. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 2009; 72:56 - 62; http://dx.doi.org/10.1212/01.wnl.0000338622.27876.0d; PMID: 19122031
   PubMed Web of Science ®Google Scholar
• Bartels AL, Willemsen AT, Doorduin J, de Vries EF, Dierckx RA, Leenders KL. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson’s disease?. Parkinsonism Relat Disord 2010; 16:57 - 9; http://dx.doi.org/10.1016/j.parkreldis.2009.05.005; PMID: 19487152
   PubMed Web of Science ®Google Scholar
• Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson’s disease. Neurobiol Dis 2006; 21:404 - 12; http://dx.doi.org/10.1016/j.nbd.2005.08.002; PMID: 16182554
   PubMed Web of Science ®Google Scholar